CRISPR Therapeutics AG (CRSP) Net Income by Year
CRISPR Therapeutics AG reported a net loss of $581.6M in fiscal year 2025. This represents a decrease of 58.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $451.1M net loss. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters CRISPR Therapeutics AG has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CRSP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
CRSP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More CRISPR Therapeutics AG financials
Frequently Asked Questions
What was CRISPR Therapeutics AG's net income in fiscal year 2025?
CRISPR Therapeutics AG reported a net loss of $581.6M in fiscal year 2025.
How fast is CRISPR Therapeutics AG's net income growing?
CRISPR Therapeutics AG (CRSP) net income fell by 58.8% year over year, from -$366.3M to -$581.6M in fiscal year 2025.
What is CRISPR Therapeutics AG's net income over the last twelve months?
CRISPR Therapeutics AG (CRSP) reported a $451.1M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has CRISPR Therapeutics AG's net income changed over the years?
Across the 12 fiscal years this page covers, CRISPR Therapeutics AG (CRSP) net income went from -$7.0M in fiscal year 2014 to -$581.6M in fiscal year 2025.
What was CRISPR Therapeutics AG's net income in the most recent quarter?
CRISPR Therapeutics AG (CRSP) reported -$91.2M in net income in Q2 2026. This represents an increase of 56.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what CRISPR Therapeutics AG (CRSP) reported on that line in every period on record.